SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%

TG Therapeutics Q1 EPS $(0.480) Down From $(0.430) YoY, Sales $38.000K, Same YoY

TG Therapeutics (NASDAQ:TGTX) reported quarterly losses of $(0.480) per share. This is a 11.63 percent decrease over losses of $(0.430) per share from the same period last year. The company reported $38.000 thousand in

Benzinga · 05/11/2020 20:01

TG Therapeutics (NASDAQ:TGTX) reported quarterly losses of $(0.480) per share. This is a 11.63 percent decrease over losses of $(0.430) per share from the same period last year. The company reported $38.000 thousand in sales this quarter. This is the same as the same period last year.